Study suggests $35 monthly insulin cap has increased patient accessnews2026-04-07T18:52:01+00:00April 7th, 2026|Endpoints News|
White House adds AbbVie’s Humira to TrumpRx alongside cheaper biosimilarsnews2026-04-07T18:10:11+00:00April 7th, 2026|Endpoints News|
ARPA-H selects three teams in $100M effort to repair and regrow ailing jointsnews2026-04-07T15:41:41+00:00April 7th, 2026|Endpoints News|
Terns sold to Merck for 13% lower than pharma’s initial offer because of clinical datanews2026-04-07T15:30:06+00:00April 7th, 2026|Endpoints News|
Novo launches high-dose Wegovy in the US; Evotec pressured to list its US unitnews2026-04-07T15:14:50+00:00April 7th, 2026|Endpoints News|
Gilead continues dealmaking streak with $3.15B Tubulis buy for ADCsnews2026-04-07T12:17:00+00:00April 7th, 2026|Endpoints News|
BioNTech to shutter Singapore HQ after ‘comprehensive review’news2026-04-07T11:20:12+00:00April 7th, 2026|Endpoints News|
Sanofi bispecific sails through asthma, sinusitis trials, but disappoints in eczemanews2026-04-07T10:44:28+00:00April 7th, 2026|Endpoints News|
Proposed FDA budget sets Makary up to boost US biotechnews2026-04-06T18:38:19+00:00April 6th, 2026|Endpoints News|
Amgen seeks to buoy Tepezza with injectable data in face of incoming competitionnews2026-04-06T15:37:41+00:00April 6th, 2026|Endpoints News|
